Usefulness of the preoperative inflammation-based prognostic score and the ratio of visceral fat area to psoas muscle area on predicting survival for surgically resected adenocarcinoma of the esophagogastric junction

被引:0
作者
Shintaro Uchida
Makoto Sohda
Kohei Tateno
Takayoshi Watanabe
Yuta Shibasaki
Nobuhiro Nakazawa
Kengo Kuriyama
Akihiko Sano
Takehiko Yokobori
Makoto Sakai
Hiroomi Ogawa
Ken Shirabe
Hiroshi Saeki
机构
[1] Gunma University Graduate School of Medicine,Department of General Surgical Science
来源
Esophagus | 2024年 / 21卷
关键词
Adenocarcinoma; Esophagogastric junction; Inflammation; Obesity paradox; Sarcopenia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:157 / 164
页数:7
相关论文
共 82 条
[1]  
Donini LM(2020)Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review Clin Nutr 39 2368-2388
[2]  
Busetto L(2022)Sarcopenic obesity: What about in the cancer setting? Nutrition 98 794-798
[3]  
Bauer JM(2016)Body fatness and cancer-viewpoint of the IARC Working Group N Engl J Med 375 46-59
[4]  
Cappellari GG(2021)Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis JAMA Netw Open 4 1304-194
[5]  
Brasacchio C(2021)Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: literature review and retrospective multicenter cohort study Ann Gastroenterol Surg 5 1230-3299
[6]  
Laudisio D(2021)Visceral obesity, metabolic syndrome, and esophageal adenocarcinoma Front Oncol 11 185-2067
[7]  
Lauby-Secretan B(2019)The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: a systematic review Cancers (Basel) 11 3288-4471
[8]  
Scoccianti C(2020)The effects of obesity on anti-cancer immunity and cancer immunotherapy Cancers (Basel) 12 66-734
[9]  
Loomis D(2022)Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma Front Oncol 12 2059-249
[10]  
Petrelli F(2018)Comparison of prognostic abilities among preoperative laboratory data indices in patients with resectable gastric and esophagogastric junction adenocarcinoma World J Surg 42 350-1605